文献速递肝胆胰外科围术期管理与 ERAS

Yonsei标准可作为左侧胰腺癌切除术后良好预后的临床可检测参数:倾向性评分匹配分析结果

The Yonsei criteria as a clinically detectable parameter for excellent prognosis in resected left-sided pancreatic cancer: outcomes of a propensity score-matched analysis.
PubMed 文献 · Surg Endosc · 2017-04-07

匹配后符合YC者短期肿瘤学结局更优,无病生存和疾病特异性总生存更好(p < 0.05)。多因素分析显示YC是无病生存的强独立预后因素(p < 0.05)。结论认为术前CT确定的YC可预测优异的短期和长期肿瘤学结局,可能作为左侧胰腺癌的术前临床分期工具,但需多中心外部验证。

要点

  • 术前CT确定的Yonsei标准可预测左侧胰腺癌切除术后短期和长期肿瘤学结局。
  • 符合YC者无病生存和疾病特异性总生存均更好(p < 0.05)。
  • YC是多因素分析中无病生存的强独立预后因素(p < 0.05)。

核心结论

  • 术前CT确定的YC可预测左侧胰腺癌切除术后优异的短期和长期肿瘤学结局。
  • YC可能作为左侧胰腺癌的术前临床分期工具。
  • YC的肿瘤学意义需基于多中心队列的外部验证确认。

主要发现

  • 符合YC者即使经过倾向性评分匹配,短期肿瘤学结局仍更优。
  • 符合YC者无病生存和疾病特异性总生存更好(p < 0.05)。
  • ROC曲线分析中,CA19-9的曲线下面积仅在YC组内令人满意。
  • 多因素分析显示YC是无病生存的强独立预后因素(p < 0.05)。
  • 术前临床分组(YC内、超出YC、不可切除)间患者生存明显不同。

关键数值与推荐

  • 符合YC者无病生存和疾病特异性总生存更优(p < 0.05)。
  • YC为无病生存的独立预后因素(p < 0.05)。

临床怎么用

  • 术前可基于CT评估YC,用于预测左侧胰腺癌切除术后肿瘤学结局。
  • YC可能辅助术前临床分期决策,但需多中心外部验证后推广。

局限性

  • 单中心回顾性研究。
  • YC的肿瘤学意义需基于多中心队列的外部验证确认。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: This study aimed to identify that Yonsei criteria (YC) can be regarded as a preoperative clinical parameter to predict biological behavior of the left-sided pancreatic cancer. METHODS: Between June 2007 and December 2014, 135 patients who underwent minimally invasive (MIS) or open distal pancreatectomy for left-sided pancreatic cancer were enrolled in this study consecutively. Perioperative short-term and long-term oncologic outcomes were analyzed according to the YC retrospectively. RESULTS: Fifty-four and 81 patients did and did not meet the YC, respectively. Short-term oncologic outcomes were favorable among those meeting the YC even after propensity score matching. Patients within the YC also had better disease-free and disease-specific overall survival (p < 0.05). In analysis for receiver operating characteristic curve, area under curve of CA19-9 was satisfactory only within YC group. Multivariate analysis for disease-free survival identified the YC as a strong independent prognostic factor (p < 0.05). In preoperative clinical setting, patients' survival was clearly different based on following clinical groups, such as within YC, beyond YC, and unresectable. CONCLUSIONS: Preoperative CT-based determined YC can predict excellent short-term and long-term oncologic outcomes. YC might have a potential role as a preoperative clinical staging for left-sided pancreatic cancer. External validations of YC based on multicenter cohorts are mandatory to confirm this oncologic significance of YC.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Lee SH, Hwang HK, Kang CM, et al. The Yonsei criteria as a clinically detectable parameter for excellent prognosis in resected left-sided pancreatic cancer: outcomes of a propensity score-matched analysis. Surg Endosc. 2017. PMID: 28389802. doi:10.1007/s00464-017-5529-6

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。